Haukeland University Hospital
Bergen, 5020, Norway
NCT Number: NCT04241822
This project is aimed at patients with dizziness believed to be due to conditions in the balance organ in the inner ear (vestibular diseases). Dizziness can be bothersome and influence postural control negatively, and can cause secondary musculoskeletal disorders. Dizziness can also result in reduced work capacity. The purpose of the project is to strengthen the knowledge base regarding symptom burden, prognosis and treatment of prolonged dizziness. The hypothesis is that musculoskeletal pain at baseline is a prognostic factor for prolonged dizziness.
Looking for future studies?
Notify Me18 year–67 year
All sexes
Interventional
Not applicable
Bergen, 5020, Norway
Patients referred to an tertiary otorhinolarynglogical clinic due to dizziness will be invited to participate in the study. The aims are to examine the prevalence, extent and distribution of musculoskeletal pain in patients with prolonged dizziness, and to investigate the associations between musculoskeletal pain, dizziness symptoms, psychological and physical function and health-related quality of life.
Furthermore, the aim is to monitor the natural course of the dizziness symptoms and functional status in these patients, and examine risk factors for prolonged disability after 6 and 12 months. The hypothesis is that muscle pain and distress at baseline may be independently associated with prolonged complaints at follow-up.
Finally, patients who still are dizzy and have pain after 12 months will be invited to participate in one of two group interventions a) modified vestibular rehabilitation and b) virtual reality / exergaming. The interventions will be feasibility studies with a pre-post design.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention is group based and is a combination of information/education, vestibular exercises (head movements and gaze stability exercises) body awareness exercises and cognitive therapy
The intervention consists of different balance exercises using non-immersive virtual reality
Time frame: Baseline, 26 weeks, 1 year, through study completion, an average 18 months
Baseline status and change in dizziness handicap
Time frame: Baseline, 26 weeks, 1 year, through study completion, an average 18 months
Baseline status and change in musculoskeletal pain
Time frame: Baseline, 26 weeks, 1 year, through study completion, an average 18 months
Baseline status and change in vertigo symptoms
Time frame: Baseline, 26 weeks, 1 year
Baseline status and change in health related quality of life
Time frame: Baseline, 26 weeks, 1 year
Baseline status and change in anxiety and depression symptoms
Time frame: Baseline, 26 weeks, 1 year, through study completion, an average 18 months
Baseline status and change in catastrophising thoughts about the dizziness
Time frame: Baseline,1 year, through study completion, an average 18 months
Baseline status and change after intervention
Time frame: Baseline,1 year, through study completion, an average 18 months
Baseline status and change after intervention
Time frame: Baseline,1 year, through study completion, an average 18 months
Baseline status and change after intervention
Time frame: Baseline,1 year, through study completion, an average 18 months
Baseline status and change after intervention
Time frame: Baseline
Baseline
Western Norway University of Applied Sciences
Other
Musculoskeletal Pain in Long-term Dizziness- Incidence, Prognosis and Measures
Acronym: MUPID
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00023049
Deafness, Ear Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT07297355
Ear Diseases, Labyrinth Diseases
Charleston, South Carolina, United States
View Trial DetailsNCT06936345
BPPV, Ear Diseases
Istanbul, Beykoz, Turkey (Türkiye)
View Trial DetailsNCT06739577
Ear Diseases, Labyrinth Diseases
Brussels, Belgium
View Trial Details